Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups
Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272)
08/2013
08/14/2013CN103240116A Catalyst for producing piperazidine and triethylenediamine and preparation method thereof
08/14/2013CN101993415B Compound as Hedgehog path inhibitor, medicine composition containing same and application thereof
08/14/2013CN101981034B Triazolopyridazines as PAR1 inhibitors, production thereof, and use as medicaments
08/14/2013CN101437816B 2-aminopyridine analogs as glucokinase activators
08/13/2013US8507676 Heterocyclic oxime compounds
08/13/2013US8507673 Process for preparing 5,7 diaminopyrazolo [1,5-A] pyrimidine compounds
08/13/2013US8507672 Substituted pyrrolo[2,3-d]pyrimidines as LIM kinase 2 inhibitors
08/13/2013US8507667 Thiolactams and uses thereof
08/13/2013US8507519 Antibacterial optically pure benzoquinolizine carboxylic acids, processes, compositions and methods of treatment
08/13/2013US8507508 Solid forms of pemetrexed
08/13/2013US8507505 Dihydropyrazolopyrimidinone derivative
08/13/2013US8507504 Process for producing bicycloaniline derivatives
08/13/2013US8507502 Fused bicyclic and tricyclic pyrimidine compounds as tyrosine kinase inhibitors
08/13/2013US8507501 Inhibitors of the BMP signaling pathway
08/13/2013US8507489 Bicyclic triazoles as protein kinase modulators
08/13/2013US8507488 Fused nitrogen containing heterocycles and compositions thereof as kinase inhibitors
08/13/2013US8507487 Certain triazolopyridines and triazolopyrazines, compositions thereof and methods of use therefor
08/13/2013US8507477 3- and 6-quinolines with N-attached heterocyclic CGRP receptor antagonists
08/13/2013US8507475 Substituted heteroarylamide diazepinopyrimidone derivatives
08/13/2013US8507472 Bicyclic pyridinylpyrazoles
08/13/2013CA2724066C Method for producing bicyclic guanidines by use of a cyclic thiourea
08/13/2013CA2670892C Substituted diazepan compounds as orexin receptor antagonists
08/13/2013CA2580409C Triazole derivative or salt thereof
08/08/2013WO2013115521A1 Novel compound, and photosensitive composition and photosensitizer containing same
08/08/2013WO2013114332A1 4-(benzoimidazol-2-yl)-thiazole compounds and related aza derivatives
08/08/2013WO2013114173A1 A novel process for the preparation of sitagliptin
08/08/2013WO2013113715A1 Fungicidal pyrimidine compounds
08/08/2013WO2013113097A1 Cyclic molecules as bruton's tyrosine kinase inhibitors
08/08/2013WO2012015810A3 Pharmaceutical compositions containing pemetrexed having extended storage stability
08/08/2013US20130203987 Ampk-activating heterocyclic compounds and methods for using the same
08/08/2013US20130203786 Substituted seven-membered heterocyclic compounds as dipeptidyl peptidase-iv inhibitors for the treatment of diabetes
08/08/2013US20130203777 Identification of Stabilizers of Multimeric Proteins
08/08/2013US20130203768 N-heteroaryl compounds with cyclic bridging unit for the treatment of parasitic diseases
08/08/2013US20130203767 Treatment of Pulmonary Hypertension
08/08/2013US20130203765 Deuterated pyrrolopyrimidine compounds as inhibitors of cdk4/6
08/08/2013US20130203755 Bicyclic heteroaryl kinase inhibitors and methods of use
08/08/2013US20130203748 Inhibitors of Human Immunodeficiency Virus Replication
08/08/2013US20130203737 Fused heterocyclic derivatives as s1p modulators
08/08/2013US20130203731 Apoptosis signal-regulating kinase 1 inhibitors
08/08/2013US20130203727 Napht-2-ylacetic acid derivatives to treat aids
08/08/2013US20130203714 Chemical compounds - 643
08/08/2013US20130202611 Use of inhibitors of bruton's tyrosine kinase (btk)
08/07/2013EP2623505A1 (aza)indolizine derivative and pharmaceutical use thereof
08/07/2013EP2622970A1 Salty taste enhancer
08/07/2013EP2621932A1 Tetracyclic heterocycle compounds for treating hepatitis c viral infection
08/07/2013EP2621931A1 Tetracyclic indole derivatives for treating hepatitis c virus infection
08/07/2013EP2621928A1 7-hydroxy-pyrazolo[1,5-a]pyrimidine compounds and their use as ccr2 receptor antagonists
08/07/2013EP2621927A1 Semiconductors based on diketopyrrolopyrroles
08/07/2013EP2621926A2 Pyrazolopyrimidine pde10 inhibitors
08/07/2013EP2621925A1 Fused tricyclic inhibitors of mammalian target of rapamycin
08/07/2013EP2621924A1 Herbicidal benzoxazinones
08/07/2013EP2621898A1 Process for the preparation of tetracyclic derivatives and intermediate products used in the process
08/07/2013CN103237799A Heterocyclic derivates, preparation processes and medical uses thereof
08/07/2013CN103232843A Electroluminescent material and application thereof
08/07/2013CN103232460A Tetramino metal phthalocyanine compound and tetramino metal phthalocyanine optical limiting high molecular material and preparation method of high molecular material
08/07/2013CN103232459A Synthesis method of semi-cucurbit[4]uril taking propyleneurea as unit
08/07/2013CN103232458A Method for preparing graphite phase carbon nitride material with monatomic layer structure
08/07/2013CN103232457A Novel carbazole-based cyclophane
08/07/2013CN103232456A Method for preparing copper chlorophyll acid from silkworm litter
08/07/2013CN103232455A Industrial production method of sitagliptin
08/07/2013CN103232454A Medicine for treating mental disease
08/07/2013CN103232453A Synthesizing method of 2-amino-5,8-dimethoxy[1,2,4]-triazolo[1,5-c]-pyrimidine
08/07/2013CN102241681B Preparation method of carboxyl-substituted metal phthalocyanine
08/07/2013CN101983189B Method for producing isoindole and isoindole produced by the method for producing isoindole
08/07/2013CN101641643B Photoactivable nitrogen bases
08/06/2013US8501961 HIV protease inhibitors and methods for using
08/06/2013US8501934 Pyrrolobenzodiazepines
08/06/2013US8501756 Heterobicyclic carboxamides as inhibitors for kinases
08/06/2013US8501753 Useful pharmaceutical salts of 7-[(3R, 4R)-3-Hydroxy-4-hydroxymethyl-pyrrolidin-1-ylmethyl]-3, 5-dihydro-pyrrolo [3, 2-D] pyrimidin-4-one
08/06/2013US8501751 Inhibitors of Bruton's tyrosine kinase
08/06/2013US8501748 Method for the production of β-ketonitriles
08/06/2013US8501738 Substituted triazolo-pyridazine derivatives
08/06/2013US8501729 5-HT3 receptor modulators, methods of making, and use thereof
08/06/2013CA2709119C Preventive or therapeutic agent for inflammatory bowel diseases
08/06/2013CA2654945C Quinoxalinyl macrocyclic hepatitis c virus serine protease inhibitors
08/06/2013CA2588513C 3-phenyl-pyrazole derivatives as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto
08/06/2013CA2525447C Amphiphilic trisulfonated porphyrazines for photodynamic applications in medicine
08/01/2013WO2013112757A1 Indole and benzofuran fused isoquinuclidene derivatives and processes for preparing them
08/01/2013WO2013112673A1 Synthetic voacangine
08/01/2013WO2013112651A2 Proteasome activity modulating compounds
08/01/2013WO2013112163A1 Indole and benzofuran fused isoquinuclidene derivatives and processes for preparing them
08/01/2013WO2013111107A1 Aminopyridine derivatives as plasma kallikrein inhibitors
08/01/2013WO2013111105A1 Imidazopyrrolidinone compounds
08/01/2013WO2013110890A1 New indolizine derivatives, method for preparing same and pharmaceutical compositions containing same
08/01/2013WO2013110768A1 Pde9 inhibitors with imidazo triazinone backbone
08/01/2013WO2013110590A1 Substituted phenylimidazopyrazoles and use thereof
08/01/2013WO2013110585A1 5, 8 -dihydro- 6h- pyrazolo [3, 4 -h] quinazolines as igf-lr/lr inhibitors
08/01/2013WO2013110309A1 Triazolo[4,5-d]pyrimidine derivatives
08/01/2013WO2013110198A1 Pyrimido[4,5-b]indole derivatives and use thereof in the expansion of hematopoietic stem cells
08/01/2013WO2013110134A1 Heterocyclic compounds and methods for their use
08/01/2013WO2013085339A3 Organic light-emitting compound and organic electroluminescent device using same
08/01/2013WO2013056070A3 Heterocyclic compounds and use thereof as modulators of type iii receptor tyrosine kinases
08/01/2013WO2010120994A3 Ureidoaryl-and carbamoylaryl-morpholino- pyrimidine compounds, their use as mtor kinase and pi3 kinase inhibitors, and their synthesis
08/01/2013US20130197223 Synthesis of substituted salicylaldehyde derivatives
08/01/2013US20130197008 3-aminocyclopentanecarboxamides as chemokine receptor agonists
08/01/2013US20130196991 Substituted indoles, antiviral active component, method for preparation and use thereof
08/01/2013US20130196986 Triazolopyrazinones as p2x7 receptor antagonists
08/01/2013US20130196985 Heterocyclic alkynyl benzene compounds and medical compositions and uses thereof
08/01/2013US20130196979 Bicyclic Heteroaryl Compounds
08/01/2013US20130196975 5-alkynyl-pyridines
1 ... 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 ... 573